Novo Nordisk A/S (OTC Pink - Current Information:NONOF)
| 98.44 Delayed Data As of Dec 05 |  -2.56 / -2.53%Today’s Change | 61.63 Today|||52-Week Range 108.51 | +44.22% Year-to-Date |
Latest NONOF News | Press Releases
Today’s Trading
| Previous close | 101.00 |
| Today’s open | 100.00 |
| Day’s range | 98.16 - 100.50 |
| Volume | 2,935 |
| Average volume (3 months) | 35,654 |
| Market cap | $350.0B |
Data as of 12/05/2023
Growth & Valuation
| Earnings growth (last year) | +4.77% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +11.71% |
| P/E ratio | -- |
| Price/Sales | 12.24 |
| Price/Book | 38.12 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NVONovo Nordisk | +0.02 | +0.02% |
| JNJJohnson & Johnson | -0.33 | -0.21% |
| MRKMerck | +0.04 | +0.04% |
| ABBVAbbVie | +0.01 | +0.01% |
Data as of 4:00pm ET, 12/05/2023
Financials
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $25.0B |
| Annual profit (last year) | $7.8B |
| Net profit margin | 31.38% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Bagsværd, Capital Region |
Forecasts
Chart unavailable
